Jazz Pharmaceuticals PLC (JAZZ) Actualités

Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire DUBLIN, Dec...

Form 8-K - Current report

Jazz Pharmaceuticals Announces CEO Succession Plan

Jazz Pharmaceuticals Announces CEO Succession Plan PR Newswire DUBLIN, Dec. 16, 2024 Bruce Cozadd, Co-Founder...

Form 4 - Statement of changes in beneficial ownership of securities

Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting

Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and...

Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii (Ziihera®)

Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice...

Form 4 - Statement of changes in beneficial ownership of securities

Jazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii) Investor Webcast on December 11, 2024

Jazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii) Investor Webcast on December 11, 2024 PR...

Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting

Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast...

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)

Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults...

Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference

Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference PR Newswire DUBLIN, Nov. 19...